Related Experiment Videos

[Chlamydia pneumoniae infection and Mycoplasma pneumoniae infection in pediatric patients]

K Ouchi1, H Komura, M Fujii

  • 1Department of Pediatrics, Saiseikai Shimonoseki General Hospital.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|February 3, 2000
PubMed

Insights

Chlamydia pneumoniae and Mycoplasma pneumoniae are common causes of pediatric lower respiratory tract infections in Japan. C. pneumoniae was more prevalent in younger children with bronchitis, while M. pneumoniae was more common in pneumonia cases.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory medicine
  • Microbiology

Context:

  • Acute lower respiratory tract infections (ALRTI) are a significant cause of pediatric morbidity.
  • Understanding the specific pathogens involved is crucial for effective treatment and public health strategies.
  • Previous data on the prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae in Japanese pediatric ALRTI cases were limited.

Purpose:

  • To determine the serological prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in pediatric patients with acute lower respiratory tract infections in Japan.
  • To compare the clinical characteristics and disease patterns associated with C. pneumoniae and M. pneumoniae infections in children.

Summary:

  • A serological evaluation of 1104 pediatric patients revealed C. pneumoniae infection in 13.5%, M. pneumoniae in 10.7%, and dual infections in 2.4%.
  • M. pneumoniae was more common in pneumonia (27.2%) than C. pneumoniae (15.4%), whereas C. pneumoniae predominated in bronchitis (12.8%) compared to M. pneumoniae (4.4%).
  • C. pneumoniae infections were associated with younger age and more frequent wheezing compared to M. pneumoniae infections.

Impact:

  • These findings highlight C. pneumoniae as a very common pathogen in pediatric lower respiratory tract infections in Japan, alongside M. pneumoniae.
  • The study provides valuable epidemiological data for clinicians managing pediatric respiratory illnesses.
  • Understanding pathogen-specific clinical features aids in differential diagnosis and targeted therapeutic approaches.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.